Multi-product proposal involving ten pharmaceuticals
PHARMAC is seeking feedback on a proposal to fund five new treatments, widen access to three currently funded treatments and change the contractual terms for two currently funded treatments through a provisional agreement with Novartis New Zealand Limited (Novartis).
Consultation closes at 5.00 pm on Monday, 23 July 2018.
Call for funding applications for medicines for rare disorders
PHARMAC invites pharmaceutical suppliers to submit funding applications for medicines for rare disorders.
This call for applications closes at 5pm on Monday 3 September 2018.
Proposal to list medical devices supplied by Atos Medical Limited and Halyard Australia Pty Limited
PHARMAC is seeking feedback on a proposal to list a range of medical devices through individual provisional agreements with Atos Medical Limited and Halyard Australia Pty Limited in Part III of Section H of the Pharmaceutical Schedule from 1 September 2018.
Consultation closes at 4pm on Tuesday 17 July 2018.
Proposal to list orthopaedic implants and associated products supplied by Surgical Specialties (NZ) Ltd
PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated products (“Orthopaedic Products”) supplied by Surgical Specialties (NZ) Limited (“Surgical Specialties”) on Section H Part III of the Pharmaceutical Schedule from 1 August 2018.
Consultation closes at 5pm on Friday 6 July 2018.
Proposal to list orthopaedic implants and associated products supplied by Orthotech Orthopaedics (NZ) Limited
PHARMAC is seeking feedback on a proposal to list a range of Orthopaedic Implants and Associated Products (“Orthopaedic Products”) supplied by Orthotech Orthopaedics (NZ) Limited (“Orthotech”), on Section H Part III of the Pharmaceutical Schedule from 1 August 2018.
Consultation closes at 5pm on Wednesday 27 June 2018.
Proposal to list Interventional Radiology products supplied by Endologix and Device Technologies
PHARMAC is seeking feedback on a proposal to list a range of Interventional Radiology Products in Part III of Section H of the Pharmaceutical Schedule from 1 August 2018 through provisional agreements with Endologix New Zealand Co (“Endologix”) and Device Technologies NZ Limited (“Device Technologies”). Closes: 5pm on Thursday 21 June 2018.
Proposal to list single use instruments supplied by B. Braun New Zealand Pty Limited
PHARMAC is seeking feedback on a proposal to list a range of single use instruments, in Part III of Section H of the Pharmaceutical Schedule from 1 August 2018, through a provisional agreement with B. Braun New Zealand Pty Limited (“B. Braun”). Closes: 4pm Friday 22 June 2018.
Proposal to list medical devices supplied by Universal Specialities Limited
PHARMAC is seeking feedback on a proposal to list a range of medical devices through a provisional agreement with Universal Specialities Limited (“USL”):
- medical thermometers;
- single use instruments; and
- medical devices used for the prevention of venous thromboembolism (“VTE Prevention”).
Closes at 4pm on Friday, 22 June 2018.
Proposal to widen access and change the funded enzyme replacement therapy for Gaucher disease
PHARMAC is seeking feedback on proposed changes to the funding of enzyme replacement therapy (ERT) used in the treatment of Gaucher disease (a rare disorder).
Consultation closes at 4 pm on Monday, 11 June 2018.
Proposal to list medical thermometers and single use instruments supplied by Jackson Allison Medical & Surgical Limited
PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 August 2018, through a provisional agreement with Jackson Allison Medical & Surgical Limited (“Jackson Allison”).
Consultation closes at 4pm on Thursday, 7 June 2018.
Proposal to list medical devices supplied by Intermed Medical Limited
PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 August 2018, through a provisional agreement with Intermed Medical Limited (“Intermed”).
Consultation closes at 4pm on Friday, 1 June 2018.
Proposal to list non-surgical antimicrobial hand hygiene products
PHARMAC is seeking feedback on a proposal to list a range of non-surgical antimicrobial hand hygiene (“Hand Hygiene”) products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2018, through provisional agreements with 3M New Zealand Limited (“3M”) and Schülke New Zealand Limited (“Schülke”).
Consultation closes at 4pm on Friday, 25 May 2018.
Proposal to list Interventional Radiology products
PHARMAC is seeking feedback on a proposal to list ranges of Interventional Radiology Products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2018 through a provisional agreement with Abbott NZ Limited (“Abbott”) and a proposed amendment to the Agreement with Defries Industries New Zealand (“Defries”).
Consultation closes at 4pm on Friday, 18 May 2018.
Proposal to list negative pressure wound therapy products and iodosorb wound care ointment supplied by Smith & Nephew Limited
PHARMAC is seeking feedback on a proposal to list a range of negative pressure wound therapy equipment and consumables (“NPWT Products”) and iodosorb wound care ointment supplied by Smith & Nephew Limited (“Smith & Nephew”) in Part III of Section H of the Pharmaceutical Schedule, effective from 1 July 2018.
Consultation closes at 4pm on Friday 24 May 2018.
Proposal to remove the funding restrictions for candesartan
Following assessment of bids in PHARMAC’s 2017/18 annual Invitation to Tender, PHARMAC is proposing to remove the Special Authority and hospital restrictions that currently apply to all strengths of candesartan.
Consultation closes at 5 pm on Monday 23 April 2018.
Proposal to list mercaptopurine oral suspension
PHARMAC is seeking feedback on a proposal to list mercaptopurine oral solution (Allmercap) 20 mg per ml from 1 June 2018, through a provisional agreement with Link Pharmaceuticals Limited.
Consultation closes at 5 pm on Friday 20 April 2018.
Proposal to list medical devices supplied by Obex Medical Limited
PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 June 2018, through a provisional agreement with Obex Medical Limited (“Obex”)
We propose to list a range of:
- medical thermometers
- single use instruments
- medical devices used in the prevention of venous thromboembolism (“VTE Prevention”)
Consultation closes at 4pm on Wednesday, 18 April 2018.
Proposal to fund aflibercept and rivaroxaban
PHARMAC is seeking feedback on a proposal to list aflibercept (Eylea) and rivaroxaban (Xarelto) through a provisional agreement with Bayer New Zealand Limited. We are also seeking feedback on a proposal to amend the current hospital restrictions for ranibizumab.
Consultation closes at 5 pm on Monday, 16 April 2018.
Proposal to list single use instruments, and orthopaedic implants and associated products
PHARMAC is seeking feedback on a proposal to list a range of single use instruments, and orthopaedic implants and associated products in Section H Part III of the Pharmaceutical Schedule from 1 June 2018 supplied by Downs Distributors New Zealand Limited and Surgico Medical and Surgical Limited.
Consultation closes at 5pm on Tuesday, 17 April 2018.
Proposal to fund denosumab for osteoporosis
PHARMAC is proposing to fund denosumab (Prolia) injections from 1 June 2018 for the treatment of severe, established osteoporosis subject to certain clinical criteria being met.
Consultation closes at 5 pm on Wednesday, 4 April 2018.
Newsletters
Device Advice: Your update on PHARMAC’s Hospital Medical Devices programme.
Hospital News: News about getting the best value for what we spend on hospital pharmaceuticals.
Inpharmation: News about PHARMAC's activities and pharmaceutical-related issues.
Inpharmation in Hospitals: Hospital news about PHARMAC's activities and pharmaceutical-related issues.
Te Whaioranga ePānui: A PHARMAC newsletter for people with an interest in Māori health.
